These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kidney transplantation in Cyprus. Kyriakides GK; Hadjigavriel M; Nicolaou P; Nicolaides A; Kyriakides M Transplant Proc; 1993 Apr; 25(2):2129-30. PubMed ID: 8470291 [No Abstract] [Full Text] [Related]
5. Role of cyclosporine rescue therapy in steroid resistant rejections. Sharma RK; Elhence R; Kher V; Gupta A; Kumar A; Bhandari M; Agrawal S Transplant Proc; 1994 Oct; 26(5):2556-7. PubMed ID: 7940789 [No Abstract] [Full Text] [Related]
6. Cyclosporin monotherapy in pancreaticorenal transplantation. Ward RG; Gecim E; Bone JM; Bakran A; Sells RA Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547 [No Abstract] [Full Text] [Related]
7. Three-day or ten-day ATG treatment for steroid-resistant rejection in kidney transplanted patients. Olausson M; Mjörnstedt L; Blohmé I Transplant Proc; 1995 Dec; 27(6):3434-5. PubMed ID: 8540037 [No Abstract] [Full Text] [Related]
8. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Kumano K; Irie A; Mashimo S; Endo T; Koshiba K Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691 [No Abstract] [Full Text] [Related]
9. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children. Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630 [No Abstract] [Full Text] [Related]
10. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation. Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571 [No Abstract] [Full Text] [Related]
11. Outcome of live-related donor renal transplants in their second decade. Georgi BA; Cacciarelli TV; Sumrani N; Goldberg K; Hong JH; Sommer BG Transplant Proc; 1993 Jun; 25(3):2164-5. PubMed ID: 8516853 [No Abstract] [Full Text] [Related]
12. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564 [TBL] [Abstract][Full Text] [Related]
14. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations. Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272 [TBL] [Abstract][Full Text] [Related]
15. Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection. Wiener Y; Nakhleh RE; Kupin WL; Lee M; Escobar FS; Venkat KK; Mozes MF Transplant Proc; 1995 Feb; 27(1):1014-5. PubMed ID: 7878781 [No Abstract] [Full Text] [Related]
16. Acute rejection after living donor renal transplantation. Cho WH; Park CH; Lee SH; Park SB; Kim HC Transplant Proc; 1994 Aug; 26(4):1995-6. PubMed ID: 8066647 [No Abstract] [Full Text] [Related]